Tcw Group Inc Guardant Health, Inc. Transaction History

Tcw Group Inc

$11.2 Billion
Q3 2024

A detailed history of Tcw Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tcw Group Inc holds 43,799 shares of GH stock, worth $1.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

43,799

Previous 52,084 15.91%

Holding current value

$1.38 Million

Previous $1.5 Million 33.24%

% of portfolio

0.01%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$22.3 - $36.29 $184,755 - $300,662	-8,285 Reduced 15.91%	43,799 $1 Million
Q2 2024 Jul 18, 2024	SELL	$16.07 - $31.84 $612,106 - $1.21 Million	-38,090 Reduced 42.24%	52,084 $1.5 Million
Q1 2024 May 09, 2024	SELL	$17.13 - $26.91 $744,915 - $1.17 Million	-43,486 Reduced 32.53%	90,174 $1.86 Million
Q4 2023 Feb 09, 2024	BUY	$21.58 - $29.5 $544,484 - $744,314	25,231 Added 23.27%	133,660 $3.62 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $1.02 Million - $1.59 Million	39,677 Added 57.71%	108,429 $3.21 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $23,934 - $43,445	1,143 Added 1.69%	68,752 $2.46 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $903,918 - $1.33 Million	39,438 Added 140.0%	67,609 $1.58 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $716,670 - $1.68 Million	28,171 New	28,171 $766,000
Q2 2021 Jul 23, 2021	SELL	$109.77 - $165.68 $6.02 Million - $9.09 Million	-54,837 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$127.04 - $179.1 $6.97 Million - $9.82 Million	54,837 New	54,837 $8.37 Million

Others Institutions Holding GH

# of Institutions

322

Shares Held

115M

Call Options Held

738K

Put Options Held

1.67M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Account